Renibus Therapeutics

Recent Finacing

Series B ext

Recent Raise

$72M

Renibus Therapeutics is a clinical-stage biopharma developing cytoprotective therapies for cardiorenal diseases, including RBT-1 preconditioning for perioperative AKI, RBT-2 for CKD, and RBT-3 iron nanoparticle.

Founded 2016

Texas, United States

11-50

Private

renibus.com

Highlights

Focus Areas

Biotechnology

Health Care

Therapeutics

Recent Investors

Financials

$167M

Total Raised

4

Funding rounds

1

Investor

Team

Upgrade to view the team

See the team members at Renibus Therapeutics.